Drug profile · INN
cephapirin sodium
CEFADYL
cephapirin sodium (CEFADYL) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — cephapirin sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
cephapirin sodium (CEFADYL) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cephapirin sodium?
cephapirin sodium (CEFADYL) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cephapirin sodium?
CEFADYL is a marketed brand name for cephapirin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cephapirin sodium?
cephapirin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.